Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Numerex Corp. was a leading provider of managed Internet of Things (IoT) and machine-to-machine (M2M) solutions, with a significant presence in the healthcare sector through its Numerex Health division. The company specialized in remote patient monitoring (RPM), telehealth, and personal emergency response systems (PERS), providing integrated solutions that combined hardware, network connectivity, and cloud-based software. Its core platform, Numerex DNA, enabled healthcare providers to monitor patients with chronic conditions in real-time, improving care coordination and reducing hospital readmissions. Numerex was a publicly traded company until its acquisition by Sierra Wireless in 2017 for approximately $107 million. Following Sierra Wireless's acquisition by Semtech in 2023, Numerex's technology and healthcare solutions have been integrated into the broader Semtech IoT portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Numerex.